c-MYC deregulation is involved in melphalan resistance of multiple myeloma: Role of PDGF-BB

C. Greco, I. D'Agnano, G. Vitelli, R. Vona, M. Marino, M. Mottolese, C. Zuppi, E. Capoluongo, F. Ameglio

Research output: Contribution to journalArticlepeer-review


Oncogenes are important regulators of cancer growth and progression and their action may be modulated by proteins of the growth factor family, such as angiogenic cytokines, known to be strongly involved in neoplastic evolution. Reciprocal interactions between oncogenes and angiogenic modulators may represent, in haematological neoplasms, including multiple myeloma (MM), a possible mechanism of drug resistance. The aim of this work is to investigate in vitro and in vivo whether or not c-myc deregulation is involved in the melphalan resistance elicited by myeloma patients and consequently to clarify the role of the angiogenic factor PDGF-BB in modulating c-myc protein expression. Fifty-one MM patients on chemotherapy with melphalan were analyzed for structural alterations of the c-myc gene, c-Myc protein expression, as well as for serum PDGF-BB release. For the in vitro study, two M14-derived established cell clones, differing for the c-Myc protein expression (c-Myc low -expressing or constitutively expressing clones) were used. Our results show that PDGF-BB is able to up-regulate Myc expression and reduce melphalan sensitivity of tumor cell clones, constitutively expressing c-myc gene product. In addition, down-regulation of c-Myc protein induces the expression of PDGF-β receptor molecules and reduces PDGF-BB release. In agreement with these results, in vivo data show that melphalan-resistant MM patients present overexpressed c-Myc protein and higher serum PDGF-β receptor levels compared to minor responding patients.

Original languageEnglish
Pages (from-to)67-79
Number of pages13
JournalInternational Journal of Immunopathology and Pharmacology
Issue number1
Publication statusPublished - Jan 2006


  • c-MYC
  • Melphalan resistance
  • MM

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'c-MYC deregulation is involved in melphalan resistance of multiple myeloma: Role of PDGF-BB'. Together they form a unique fingerprint.

Cite this